Ras Activity in Acinar Cells Links Chronic Pancreatitis and Pancreatic Cancer

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 11 SUPPL., 2009, Pages

  Logsdon, Craig D ^a   Ji, Baoan ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; RAS PROTEIN;

ACINAR CELL; ARTICLE; CANCER GROWTH; CANCER RISK; CELL DEATH; CHROMOSOMAL INSTABILITY; CHRONIC PANCREATITIS; CYSTIC FIBROSIS; GENE ACTIVATION; GENE MUTATION; HUMAN; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREATIC DUCTAL ADENOCARCINOMA; STROMA CELL;

ADENOCARCINOMA; CARCINOMA, PANCREATIC DUCTAL; GENES, RAS; HUMANS; MODELS, BIOLOGICAL; PANCREATITIS, CHRONIC; SIGNAL TRANSDUCTION;

EID: 71849107983     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.07.040     Document Type: Article

References (46)

1. Ji B., Tsou L., Wang H., et al. Ras activity levels control the development of pancreatic diseases. 2009. Gastroenterology 137 (2009) 1072-1082
2. Logsdon CD, Ji B, Hwang R. Novel molecular relationships between chronic pancreatitis and pancreatic cancer. In: Neoptolemos JPU, Abbruzzese R, Büchler MW, eds. Handbook of pancreatic cancer. New York: Springer (in press).
3. Steer M.L., Waxman I., and Freedman S. Chronic pancreatitis. N Engl J Med 332 (1995) 1482-1490
4. Witt H., Apte M.V., Keim V., et al. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 132 (2007) 1557-1573
5. Seymour A.B., Hruban R.H., Redston M., et al. Allelotype of pancreatic adenocarcinoma. Cancer Res 54 (1994) 2761-2764
6. Mutema G., and Fenoglio-Preiser C. Pathology and natural history of pancreatic cancer. In: Abbruzzese J.L. (Ed). Gastrointestinal oncology (2004), Oxford University Press, New York
7. Ekbom A., McLaughlin J.K., Karlsson B.M., et al. Pancreatitis and pancreatic cancer: a population-based study. J Natl Cancer Inst 86 (1994) 625-627
8. Malka D., Hammel P., Maire F., et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 51 (2002) 849-852
9. Bansal P., and Sonnenberg A. Pancreatitis is a risk factor for pancreatic cancer. Gastroenterology 109 (1995) 247-251
10. Lowenfels A.B., Maisonneuve P., Cavallini G., et al. Pancreatitis and the risk of pancreatic cancer: International Pancreatitis Study Group. 1993. N Engl J Med 328 (1993) 1433-1437
11. Lowenfels A.B., Maisonneuve P., DiMagno E.P., et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 89 (1997) 442-446
12. Whitcomb D.C. Inflammation and cancer: V-chronic pancreatitis and pancreatic cancer. Am J Physiol Gastrointest. Liver Physiol 287 (2004) G315-G319
13. Takaori K., Hruban R.H., Maitra A., et al. Current topics on precursors to pancreatic cancer. Adv Med Sci 51 (2006) 23-30
14. Maitra A., Fukushima N., Takaori K., et al. Precursors to invasive pancreatic cancer. Adv Anat Pathol 12 (2005) 81-91
15. Rosty C., Geradts J., Sato N., et al. p16 inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis. Am J Surg Pathol 27 (2003) 1495-1501
16. Volkholz H., Stolte M., and Becker V. Epithelial dysplasias in chronic pancreatitis. Virchows Arch A Pathol Anat Histol 396 (1982) 331-349
17. Hermanova M., Nenutil R., Kren L., et al. Proliferative activity in pancreatic intraepithelial neoplasias of chronic pancreatitis resection specimens: detection of a high-risk lesion. Neoplasma 51 (2004) 400-404
18. Brentnall T.A., Chen R., Lee J.G., et al. Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res 55 (1995) 4264-4267
19. Almoguera C., Shibata D., Forrester K., et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53 (1988) 549-554
20. Ren Y.X., Xu G.M., Li Z.S., et al. Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases. World J Gastroenterol 10 (2004) 881-884
21. Sawada Y., Gonda H., and Hayashida Y. Combined use of brushing cytology and endoscopic retrograde pancreatography for the early detection of pancreatic cancer. Acta Cytol 33 (1989) 870-874
22. Kubota Y., Takaoka M., Tani K., et al. Endoscopic transpapillary biopsy for diagnosis of patients with pancreaticobiliary ductal strictures. Am J Gastroenterol 88 (1993) 1700-1704
23. Arvanitakis M., Van Laethem J.L., Parma J., et al. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation. Endoscopy 36 (2004) 535-542
24. Lohr M., Maisonneuve P., and Lowenfels A.B. K-Ras mutations and benign pancreatic disease. Int J Pancreatol 27 (2000) 93-103
25. Berthelemy P., Bouisson M., Escourrou J., et al. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 123 (1995) 188-191
26. Hsiang D., Fries H., Buchler M.W., et al. Absence of K-ras mutations in the pancreatic parenchyma of patients with chronic pancreatitis. Am J Surg 174 (1997) 242-246
27. Nakaizumi A., Uehara H., Takenaka A., et al. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy. Hepatogastroenterology 46 (1999) 31-37
28. Lohr M., Kloppel G., Maisonneuve P., et al. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia 7 (2005) 17-23
29. Deramaudt T., and Rustgi A.K. Mutant KRAS in the initiation of pancreatic cancer. Biochim Biophys Acta 1756 (2005) 97-101
30. Klein W.M., Hruban R.H., Klein-Szanto A.J., et al. Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression. Mod Pathol 15 (2002) 441-447
31. Klimstra D.S., and Longnecker D.S. K-ras mutations in pancreatic ductal proliferative lesions. Am J Pathol 145 (1994) 1547-1550
32. Andea A., Sarkar F., and Adsay V.N. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 16 (2003) 996-1006
33. Ji B., Song J., Tsou L., et al. Activation of K-RAS in pancreatic acinar cells causes chronic pancreatitis in transgenic mice. Gastroenterology 132 (2007) A116-A117
34. Hingorani S.R., Petricoin E.F., Maitra A., et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4 (2003) 437-450
35. Aguirre A.J., Bardeesy N., Sinha M., et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 17 (2003) 3112-3126
36. Carriere C., Seeley E.S., Goetze T., et al. The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia. Proc Natl Acad Sci U S A 104 (2007) 4437-4442
37. Guerra C., Schuhmacher A.J., Canamero M., et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11 (2007) 291-302
38. Brembeck F.H., Schreiber F.S., Deramaudt T.B., et al. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Cancer Res 63 (2003) 2005-2009
39. Duan R.D., Zheng C.F., Guan K.L., et al. Activation of MAP kinase kinase (MEK) and Ras by cholecystokinin in rat pancreatic acini. Am J Physiol 268 (1995) G1060-G1065
40. Muller-Decker K., Furstenberger G., Annan N., et al. Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice. Gastroenterology 130 (2006) 2165-2178
41. Wagner M., Greten F.R., Weber C.K., et al. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev 15 (2001) 286-293
42. Pandol S.J., Gukovsky I., Satoh A., et al. Animal and in vitro models of alcoholic pancreatitis: role of cholecystokinin. Pancreas 27 (2003) 297-300
43. Colby J.K., Klein R.D., McArthur M.J., et al. Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression. Neoplasia 10 (2008) 782-796
44. Carriere C., Young A.L., Gunn J.R., et al. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem Biophys Res Commun 382 (2009) 561-565
45. Siveke J.T., Einwachter H., Sipos B., et al. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell 12 (2007) 266-279
46. Maitra A., and Hruban R.H. Pancreatic cancer. Annu Rev Pathol 3 (2008) 157-188